article thumbnail

Developing Global Leaders Is America's Competitive Advantage

Harvard Business Review

has become a Mecca for international scientists, engineers and business students — particularly those undertaking graduate studies. In 2011, 71% of HBS's new cases were written about foreign companies. Let's examine the reasons why America possesses this important advantage: 1.

article thumbnail

Technology Progresses When Business, Government, and Academia Work Together

Harvard Business Review

The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. The key to making these organizations work is integrating the work of discovery-driven researchers, applied scientists, and engineers in the private sector. The Era of Big Science. Innovating the Innovation Process.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

India Remakes Global Innovation

Harvard Business Review

In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Suzlon's head of technology is John O'Halloran, a former Cummins Engine executive who now leads Suzlon's 500-strong global R&D team out of Hamburg. facility in Cambridge Science Park. and the U.K.

article thumbnail

It's Manufacturing's Turn for Special Treatment

Harvard Business Review

And one look at the trade deficit ($558 billion in 2011) clearly indicates we don't have as much as our foreign competitors to sell in return. Production engineering is hard to do without a factory (it's like being a cook without a kitchen). To make up the difference, we just borrow. Strengthening the industrial base.

article thumbnail

The Industries Plagued by the Most Uncertainty

Harvard Business Review

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.